Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2013 1
2014 5
2015 7
2017 3
2018 2
2019 6
2020 7
2021 3
2022 5
2023 6
2024 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A.
von Drygalski A, Chowdary P, Kulkarni R, Susen S, Konkle BA, Oldenburg J, Matino D, Klamroth R, Weyand AC, Jimenez-Yuste V, Nogami K, Poloskey S, Winding B, Willemze A, Knobe K; XTEND-1 Trial Group. von Drygalski A, et al. Among authors: matino d. N Engl J Med. 2023 Jan 26;388(4):310-318. doi: 10.1056/NEJMoa2209226. N Engl J Med. 2023. PMID: 36720133 Clinical Trial.
International consensus recommendations on the management of people with haemophilia B.
Hart DP, Matino D, Astermark J, Dolan G, d'Oiron R, Hermans C, Jiménez-Yuste V, Linares A, Matsushita T, McRae S, Ozelo MC, Platton S, Stafford D, Sidonio RF Jr, Tiede A. Hart DP, et al. Among authors: matino d. Ther Adv Hematol. 2022 Apr 2;13:20406207221085202. doi: 10.1177/20406207221085202. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35392437 Free PMC article. Review.
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.
Cuker A, Kavakli K, Frenzel L, Wang JD, Astermark J, Cerqueira MH, Iorio A, Katsarou-Fasouli O, Klamroth R, Shapiro AD, Hermans C, Ishiguro A, Leavitt AD, Oldenburg JB, Ozelo MC, Teitel J, Biondo F, Fang A, Fuiman J, McKay J, Sun P, Rasko JEJ, Rupon J; BENEGENE-2 Trial Investigators. Cuker A, et al. N Engl J Med. 2024 Sep 26;391(12):1108-1118. doi: 10.1056/NEJMoa2302982. N Engl J Med. 2024. PMID: 39321362 Clinical Trial.
AhR-Mediated, Non-Genomic Modulation of IDO1 Function.
Pallotta MT, Fallarino F, Matino D, Macchiarulo A, Orabona C. Pallotta MT, et al. Among authors: matino d. Front Immunol. 2014 Oct 15;5:497. doi: 10.3389/fimmu.2014.00497. eCollection 2014. Front Immunol. 2014. PMID: 25360135 Free PMC article. Review.
Molecular Mechanisms of Inhibitor Development in Hemophilia.
Tieu P, Chan A, Matino D. Tieu P, et al. Among authors: matino d. Mediterr J Hematol Infect Dis. 2020 Jan 1;12(1):e2020001. doi: 10.4084/MJHID.2020.001. eCollection 2020. Mediterr J Hematol Infect Dis. 2020. PMID: 31934311 Free PMC article. Review.
Amino acid metabolism as drug target in autoimmune diseases.
Mondanelli G, Iacono A, Carvalho A, Orabona C, Volpi C, Pallotta MT, Matino D, Esposito S, Grohmann U. Mondanelli G, et al. Among authors: matino d. Autoimmun Rev. 2019 Apr;18(4):334-348. doi: 10.1016/j.autrev.2019.02.004. Epub 2019 Feb 22. Autoimmun Rev. 2019. PMID: 30797943 Free article. Review.
50 results